Latest news
Durvalumab Plus BCG Improves Outcomes in High-Risk Non–Muscle-Invasive Bladder Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 16:07:30 GMTPalm Beach Gardens Medical Center is Only Hospital Between Miami and Orlando to Utilize Innovative Imaging Agent to Improve Detection of Certain Bladder Cancers - Florida Hospital News and Healthcare ReportFlorida Hospital News and Healthcare Report · Fri, 07 Aug 2026 11:31:21 GMTNew Combination Therapy Shows Promise for Advanced Bladder Cancer - CU Anschutz newsroomCU Anschutz newsroom · Thu, 06 Aug 2026 19:17:45 GMTNeoadjuvant Sacituzumab Govitecan in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer - Brigida Maiorano - UroTodayUroToday · Thu, 06 Aug 2026 00:32:57 GMTNCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms - CancerNetworkCancerNetwork · Wed, 05 Aug 2026 18:04:30 GMTPresumed Simultaneous Intraocular and Extraocular BCG-osis as a Complication of Intravesical Bacillus Calmette-Guérin Treatment for Non-Muscle-Invasive Bladder Cancer: A Case Report - CureusCureus · Wed, 05 Aug 2026 17:26:24 GMTHealth Canada Approves KEYTRUDA® for the treatment of adult patients with muscle invasive bladder cancer who are ineligible for cisplatin containing chemotherapy, in combination with enfortumab vedotin, as neoadjuvant treatment and then continued after - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 15:00:00 GMTNatera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 10:00:00 GMT